Factory selling COVID-19 RBD antibody - SARS-CoV-2 Neutralizing Antibody Rapid Test (Colloidal Gold) – Genobio
Factory selling COVID-19 RBD antibody - SARS-CoV-2 Neutralizing Antibody Rapid Test (Colloidal Gold) – Genobio Detail:
Product Introduction
Virusee® SARS-CoV-2 Neutralizing Antibody Rapid Test (Colloidal Gold) uses colloidal gold method for the in vitro qualitative detection of the COVID-19 neutralizing antibodies in human whole blood, serum, plasma, or fingertip blood samples. It is mainly used to monitor the infection rate of herd immunity and protective immunity, and evaluate the efficacy of the Novel Coronavirus vaccine.
The neutralizing antibodies are produced in the blood as a result of immune response. They provide protection against future infections from viruses, because they remain in the circulatory system for months to years after infection and will bind quickly and strongly to the pathogen to block cellular infiltration and replication.
Characteristics
|
Name |
SARS-CoV-2 Neutralizing Antibody Rapid Test (Colloidal Gold) |
|
Method |
Colloidal Gold |
|
Sample type |
Whole blood, Serum, Plasma, Fingertip blood |
|
Specification |
1 test/kit, 20 tests/kit |
|
Detection time |
10 min |
|
Detection objects |
SARS-CoV-2 |
|
Stability |
Stable for 12 months at 2-30°C |
|
Sensitivity |
98.56% |
|
Specificity |
99.65% |
Advantage
- Various options
Sample type: whole blood, serum, plasma and fingertip blood
Specifications: VNAbLFA-01: 1 test/kit. VNAbLFA-20: 20 tests/kit - Simple & Convenient
Visual-reading result, more intuitive, less complicated calculation
No sample preparation needed
Minimum manual operation & detailed instructions
- Cost-effective
Transport and store at room temperature
Basic tools are provided with the kit - Quantitative results available using Immunochromatography Analyzer!
- Included in China white list
Principle
SARS-CoV-2 Neutralizing Antibody Rapid Test (Colloidal Gold) adopts a colloidal gold method based on the principle of the double antigen-sandwich technique. During testing, the specimen migrates upward under capillary action. The SARS-CoV-2 Neutralizing Antibodies, if present in the specimen, will bind to the S-RBD antigen-colloidal gold complex formed immune complex, the immune complex is then captured on the membrane by the pre-coated S-RBD antigen on the T-line, and a visible colored line will show up in the test line region indicating a positive result. In the absence of SARS-CoV-2 Neutralizing Antibodies, no colored line will form in the test line region, which indicating a negative result. To serve as a procedural control, a colored line will always appear at the control line region, indicating that proper volume of specimen has been added and membrane wicking has occurred.
Test process
Note: Please read the instruction for use carefully before use
Order Information
|
Model |
Description |
Product code |
|
VNAbLFA-01 |
1 test/kit |
CoVNAbLFA-01 |
|
VNAbLFA-20 |
20 tests/kit |
CoVNAbLFA-20 |
Product detail pictures:
Related Product Guide:
It truly is our responsibility to fulfill your requirements and successfully provide you. Your fulfillment is our best reward. We're seeking forward in your check out for joint development for Factory selling COVID-19 RBD antibody - SARS-CoV-2 Neutralizing Antibody Rapid Test (Colloidal Gold) – Genobio , The product will supply to all over the world, such as: Korea, United Arab Emirates, Norway, With the development and enlargement of mass clients abroad, now we have set up cooperative relationships with many major brands. We have our own factory and also have many reliable and well-cooperated factories in the field. Adhering to the "quality first, customer first, We are provideing high-quality, low-cost products and first-class service to customers. We sincerely hope to establish business relationship with customers from all over the world on the basis of quality, mutually benefit. We welcome OEM projects and designs.
By Aurora from Argentina - 2017.12.19 11:10
Problems can be quickly and effectively resolved, it is worth to be trust and working together.
By Eleanore from Israel - 2017.11.11 11:41
